2024, Vol. 6, Issue 11, Part A

Purpose: This comprehensive review aims to explore the effectiveness of PBMT in the regulation of axial length and its potential implications for myopia management.

Methodology: A systematic review of the current literature was conducted using databases such as PubMed, Medline and Google scholar. Studies examining the effects of PBMT on axial length in both clinical trials were included. Data were extracted and analyzed for parameters such as wavelength, dosage, treatment duration, and outcomes related to axial length changes.

Results: The review revealed that PBMT shows promise in influencing axial length growth, with several studies demonstrating significant reduction in axial elongation. The effects were found to be wavelength-dependent, with certain wavelengths proving more effective than others. Treatment dosage and duration were also critical factors influencing outcomes. However, variability in study design and heterogeneity in patient populations highlight the need for standardized protocols and larger-scale trials.

Conclusion: Photobiomodulation therapy presents a promising, non-invasive approach to axial length management, potentially offering a new pathway for myopia control. While preliminary results are encouraging, further research with standardized methodologies is necessary to fully understand the therapeutic potential and to optimize treatment protocols for clinical application.